Cargando…
In Vivo Efficacy of the Combination of Ciprofloxacin and Cefotaxime against Vibrio vulnificus Sepsis
OBJECTIVES: The in vivo efficacy of a cefotaxime-ciprofloxacin combination against Vibrio vulnificus and the effects on rtxA1 expression of commonly used antibiotics are unknown. METHODS: In vitro time-kill studies were performed to evaluate synergism. Female BALB/c mice were injected subcutaneously...
Autores principales: | Jang, Hee-Chang, Choi, Su-Mi, Kim, Hee Kyung, Kim, Sung-Eun, Kang, Seung-Ji, Park, Kyung-Hwa, Ryu, Phil Youl, Lee, Tae-Hoon, Kim, Young Ran, Rhee, Joon Haeng, Jung, Sook-In, Choy, Hyon E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076242/ https://www.ncbi.nlm.nih.gov/pubmed/24978586 http://dx.doi.org/10.1371/journal.pone.0101118 |
Ejemplares similares
-
In Vivo Efficacy of Tigecycline-based Therapy Against Vibrio vulnificus Sepsis: Comparison with pre-Existing Regimens
por: Eun Kim, Seong, et al.
Publicado: (2017) -
Integrative genome-scale metabolic analysis of Vibrio vulnificus for drug targeting and discovery
por: Kim, Hyun Uk, et al.
Publicado: (2011) -
Outcomes of Third-Generation Cephalosporin Plus Ciprofloxacin or Doxycycline Therapy in Patients with Vibrio vulnificus Septicemia: A Propensity Score-Matched Analysis
por: Kim, Seong Eun, et al.
Publicado: (2019) -
TolCV1 Has Multifaceted Roles During Vibrio vulnificus Infection
por: Gong, Yue, et al.
Publicado: (2021) -
Effects of Pyrogallol on Growth and Cytotoxicity of Wild-Type and katG Mutant Strains of Vibrio vulnificus
por: Lim, Ju Young, et al.
Publicado: (2016)